Should I buy or sell Raia Drogasil stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Raia Drogasil in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" RADLY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RADLY, but not buy additional shares or sell existing shares. View RADLY analyst ratings or view top-rated stocks .

How have RADLY shares performed in 2024?

Raia Drogasil's stock was trading at $7.20 at the start of the year. Since then, RADLY stock has decreased by 30.6% and is now trading at $5.00. View the best growth stocks for 2024 here .

How often does Raia Drogasil pay dividends? What is the dividend yield for Raia Drogasil?

Raia Drogasil declared a dividend on Friday, December 22nd. Stockholders of record on Tuesday, January 2nd will be given a dividend of $0.0088 per share on Monday, January 8th. The ex-dividend date is Friday, December 29th. This is a positive change from the stock's previous dividend of $0.01. Read our dividend analysis for RADLY .

When did Raia Drogasil's stock split?

Raia Drogasil's stock split on Monday, May 22nd 2023. The 26-25 split was announced on Monday, May 22nd 2023. The newly issued shares were distributed to shareholders after the closing bell on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the split would have 104 shares after the split.

How do I buy shares of Raia Drogasil?

Shares of RADLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:RADLY

Raia Drogasil (RADLY) Stock Price, News & Analysis

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Free RADLY Stock Alerts

$5.00

-0.01 (-0.20%)

(As of 04/26/2024 ET)

Compare

Today's Range: $5.00
▼
$5.00
50-Day Range: $5.00
▼
$6.50
52-Week Range: $4.22
▼
$8.25

Volume: 100 shs
Average Volume: 1,929 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Dividend Short Interest

Get Raia Drogasil alerts:

Ad Investing Daily

His win rate puts Warren Buffett to shame…

Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.

Click here now for the full story.

About Raia Drogasil Stock (OTCMKTS:RADLY)

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It also markets its goods through telesales and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

RADLY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RADLY Stock News Headlines

July 8, 2022 | finance.yahoo.com

Brazil’s Battered Stocks Could Rebound, but Not Before the Presidential Vote

May 5, 2022 | uk.investing.com

Raia Drogasil SA ADR (RADLY)

See More Headlines

Receive RADLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Raia Drogasil and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 6/10 Dividend: 4/18/2024
Today: 4/28/2024
Dividend Payable: 6/10/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical Retailers
Sub-Industry: N/A
Current Symbol: OTCMKTS:RADLY
CUSIP: N/A
CIK: N/A
Web: www.rd.com.br
Phone: 551137695678
Fax: N/A
Employees: 57,700
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Marcílio D'Amigo Pousada (Age 59)
CEO & Member of Executive Board
Mr. Antonio Carlos Coelho
VP of Finance & Administrative and Member of Executive Board
Mr. Eugênio De Zagottis
VP of Corporate Planning, IR, M&A and Member of Executive Board
Mr. Marcello De Zagottis
VP of Commercial & Marketing and Member of Executive Board
Mr. Fernando Kozel Varela
VP of Digital Transformation & Member of Executive Board
Mr. Renato Cepollina Raduan
VP of Store, Multichannel & Expansion Operations and Member of Executive Board
Ms. Maria Susana De Souza
VP of People, Culture & Sustainability and Member of Executive Board
Mr. Bruno Wright Pipponzi
VP of Health Business & Member of Executive Board
Celso Pissi Filho
Accountant & Technical Manager
Flavio Fogaca
Director of IR, Corporate Affairs & Strategy

Key Competitors

View All Competitors

RADLY Stock Analysis - Frequently Asked Questions

Should I buy or sell Raia Drogasil stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Raia Drogasil in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" RADLY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RADLY, but not buy additional shares or sell existing shares.
View RADLY analyst ratings or view top-rated stocks.
How have RADLY shares performed in 2024?: Raia Drogasil's stock was trading at $7.20 at the start of the year. Since then, RADLY stock has decreased by 30.6% and is now trading at $5.00.
View the best growth stocks for 2024 here.
How often does Raia Drogasil pay dividends? What is the dividend yield for Raia Drogasil?: Raia Drogasil declared a dividend on Friday, December 22nd. Stockholders of record on Tuesday, January 2nd will be given a dividend of $0.0088 per share on Monday, January 8th. The ex-dividend date is Friday, December 29th. This is a positive change from the stock's previous dividend of $0.01.
Read our dividend analysis for RADLY.

When did Raia Drogasil's stock split?: Raia Drogasil's stock split on Monday, May 22nd 2023. The 26-25 split was announced on Monday, May 22nd 2023. The newly issued shares were distributed to shareholders after the closing bell on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the split would have 104 shares after the split.
How do I buy shares of Raia Drogasil?: Shares of RADLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RADLY) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial